Equities Analysts Set Expectations for TSE:BHC Q1 Earnings

Bausch Health Companies Inc. (TSE:BHC) – Investment analysts at Zacks Research dropped their Q1 2026 earnings per share estimates for shares of Bausch Health Companies in a research report issued to clients and investors on Wednesday, March 11th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $1.10 for the quarter, down from their previous forecast of $1.13. The consensus estimate for Bausch Health Companies’ current full-year earnings is $5.55 per share. Zacks Research also issued estimates for Bausch Health Companies’ Q3 2026 earnings at $1.44 EPS, Q4 2026 earnings at $1.49 EPS, FY2026 earnings at $5.32 EPS, Q1 2027 earnings at $1.11 EPS, Q2 2027 earnings at $1.20 EPS, Q4 2027 earnings at $1.32 EPS and FY2027 earnings at $5.15 EPS.

Bausch Health Companies (TSE:BHC) last released its quarterly earnings data on Wednesday, February 18th. The company reported C($0.41) EPS for the quarter. Bausch Health Companies had a net margin of 1.82% and a negative return on equity of 20.27%. The company had revenue of C$6.62 billion during the quarter.

A number of other brokerages also recently weighed in on BHC. Barclays upgraded shares of Bausch Health Companies to a “hold” rating in a research report on Monday, December 8th. Raymond James Financial raised shares of Bausch Health Companies to a “hold” rating in a research note on Monday, December 15th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has an average rating of “Hold”.

Bausch Health Companies Price Performance

Bausch Health Companies stock opened at C$6.89 on Thursday. The company has a current ratio of 1.47, a quick ratio of 0.58 and a debt-to-equity ratio of -3,835.02. The firm has a market capitalization of C$2.55 billion, a P/E ratio of 16.40, a PEG ratio of 0.21 and a beta of 0.60. The business has a 50-day moving average of C$8.56 and a 200-day moving average of C$9.07. Bausch Health Companies has a 1 year low of C$5.91 and a 1 year high of C$11.97.

Bausch Health Companies Company Profile

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.